Abstract
Objective
The aim of the current study is to evaluate the effect of insulin-like growth factor-I (IGF-I) on the production of vascular endothelial growth factor (VEGF) in the human fallopian tube.
Methods
Human oviductal epithelial cells (OEC) and oviductal stromal fibroblasts (OSF) were isolated from the ampullary segment of the fallopian tubes of six premenopausal patients in the proliferative phase of the menstrual cycle. The secretion of VEGF165 by cultured OEC and OSF in response to IGF-1 was measured using an enzyme-linked immunosorbent assay (ELISA).
Results
The secretion of VEGF165 was detected in cultured OEC and OSF under untreated conditions. The secretion of VEGF165 was significantly stimulated with IGF-I administration in these cells.
Conclusion
The present findings suggest that IGF-I in the local environment may stimulate oviductal vascular permeability by inducing the production of VEGF by oviductal cells through autocrine and paracrine mechanisms. The modulation of the VEGF production in the fallopian tube may contribute to the normal and pathologic processes of oviductal fluid secretion by regulating oviductal vascular permeability during the menstrual cycle and in the peri-implantation period.
Similar content being viewed by others
References
Boatman DE. Responses of gametes to the oviductal environment. Hum Reprod 1997;12: 133–49.
Verhage HG, Fazleabas AT, Donnelly K. The in vitro synthesis and release of proteins by the human oviduct. Endocrinology 1988;122: 1639–45.
Willis P, Sekhar KN, Brooks P, Fayrer-Hosken RA. Electro-phoretic characterization of equine oviductal fluid. J Exp Zool 1994;268: 477–85.
Leese HJ. The formation and function of oviduct fluid. J Reprod Fertil 1988;82: 843–56.
Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial mitogen related to PDGF. Science 1989;246: 1309–12.
Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246: 1306–9.
Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11947–54.
Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219: 983–5.
Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB. Vascular endothelial growth factor localization in human ovary and fallopian tubes: Possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab 1996;81: 353–9.
Lam PM, Briton-Jones C, Cheung CK, et al. Vascular endothelial growth factor in the human oviduct: Localization and regulation of messenger RNA expression in vivo. Biol Reprod 2003; 68: 1870–6.
Itoh H, Nasu K, Matsumoto H, Kawano Y, Yoshimatsu J, Narahara H. Hypoxia regulates vascular endothelial growth factor and soluble fins-like tyrosine kinase-1 secretion by human oviductal epithelial cells and stromal fibroblasts. Fertil Steril 2006;85(Suppl 1):1097–102.
Lam PM, Briton-Jones C, Cheung C, et al. In vivo regulation of mRNA expression of vascular endothelial growth factor receptors (KDR & flt-1) in the human oviduct. Fertil Steril 2004;81: 416–23.
Stanke DF, Sikes JD, DeYoung DW, Tumbleson ME. Proteins and amino acids in bovine oviductal fluid. J Reprod Fertil 1974;38: 493–6.
Giudice L. Insulin-like growth factor and ovarian follicular development. Endocrine Rev 1992;13: 1304–6.
Giudice LC. Growth factors and growth modulators in human uterine endometrium: Their potential relevance to reproductive medicine. Fertil Steril 1994;61: 1–17.
Pfeifer T, Chegini N. Immunohistochemical localization of insulin-like growth factor (IGF-I), IGF-I receptor, and IGF binding protein 1–4 in human fallopian tube at various reproductive stages. Biol Reprod 1994;50: 281–9.
Sara VR, Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev 1990;70: 591–614.
Jin H-Y, Wang Z-N. Insulin-like growth factors and their receptors in human fallopian tube in reproductive-age women. Fertil Steril 2001;75: 1037–8.
Lighten AD, Moore GE, Winston RML, Hardy K. Routine addition of human insulin-like growth factor-I ligand could benefit clinical in-vitro fertilization culture. Hum Reprod 1998; 13: 3144–50.
Smotrich DB, Stillman RJ, Widra EA, et al. Immunocytochemical localization of growth factors and their receptors in human pre-embryos and Fallopian tubes. Hum Reprod 1996;11: 184–90.
Suzuki T, Sasano H, Takaya R, Fukaya T, Yajima A, Nagura H. Cyclic changes of vasculature and vascular phenotypes in normal human ovaries. Hum Reprod 1998;13: 953–9.
Maas J W, Groothuis PG, Dunselman GA, de Goeij AF, Struyker Boudier HA, Evers JL. Endometrial angiogenesis throughout the human menstrual cycle. Hum Reprod 2001;16: 1557–61.
Olofsson B, Korpelainen E, Pepper MS, et al. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Nad Acad Sci USA 1998;95: 11709–14.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (no. 16591672 to K.N.).
Rights and permissions
About this article
Cite this article
Nasu, K., Itoh, H., Yuge, A. et al. Insulin-like Growth Factor-I Regulates Vascular Endothelial Growth Factor Secretion by Human Oviductal Epithelial Cells and Stromal Fibroblasts. Reprod. Sci. 13, 368–371 (2006). https://doi.org/10.1016/j.jsgi.2006.03.007
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jsgi.2006.03.007